Broad-spectrum antiviral activity of antisense oligonucleotides targeting GBF1 against SARS-CoV-2 and influenza viruses

Authors:

Abstract
No abstract available
Funding Information
  • Japan Agency for Medical Research and Development (JP19fk0108113)
  • Japan Agency for Medical Research and Development (JP223fa727001)
  • Japan Agency for Medical Research and Development (JP223fa627002)
  • Japan Agency for Medical Research and Development (JP22gm1610010)
  • Japan Society for the Promotion of Science (JP22H02521)
  • Japan Society for the Promotion of Science (JP24K09264)
  • Research Institute for Microbial Diseases, Osaka University
  • Takeda Science Foundation

This publication has 62 references indexed in Scilit: